0001980518-26-000001.txt : 20260102 0001980518-26-000001.hdr.sgml : 20260102 20260102142723 ACCESSION NUMBER: 0001980518-26-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260102 DATE AS OF CHANGE: 20260102 EFFECTIVENESS DATE: 20260102 FILER: COMPANY DATA: COMPANY CONFORMED NAME: HYKU BIOSCIENCES INC. CENTRAL INDEX KEY: 0001980518 ORGANIZATION NAME: EIN: 863072711 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-568760 FILM NUMBER: 26501858 BUSINESS ADDRESS: STREET 1: 5 BURLINGTON WOODS DR. STREET 2: SUITE 103A CITY: BURLINGTON STATE: MA BUSINESS PHONE: 877-381-2125 MAIL ADDRESS: STREET 1: 5 BURLINGTON WOODS DR. STREET 2: SUITE 103A CITY: BURLINGTON STATE: MA FORMER COMPANY: FORMER CONFORMED NAME: Umbra Therapeutics Inc. DATE OF NAME CHANGE: 20230607 D 1 primary_doc.xml X0708 D LIVE 0001980518 HYKU BIOSCIENCES INC. 5 BURLINGTON WOODS DR. SUITE 103A BURLINGTON MA MASSACHUSETTS 01803 877-381-2125 DELAWARE Endor Therapeutics Inc. Umbra Therapeutics Inc. Corporation true 2021 KLEEM CHAUDHARY 5 BURLINGTON WOODS DR. SUITE 103A BURLINGTON MA MASSACHUSETTS 01803 Executive Officer Director Promoter LAURA TADVALKAR 5 BURLINGTON WOODS DR. SUITE 103A BOSTON MA MASSACHUSETTS 01803 Director MATTHIAS VAN WOENSEL 5 BURLINGTON WOODS DR. SUITE 103A BOSTON MA MASSACHUSETTS 01803 Director LAURA BRASS 5 BURLINGTON WOODS DR. SUITE 103A BOSTON MA MASSACHUSETTS 01803 Director JOHN GUSTOFSON 5 BURLINGTON WOODS DR. SUITE 103A BOSTON MA MASSACHUSETTS 01803 Director Other Decline to Disclose 06b false 2025-12-10 false true true false 0 21000000 6600000 14400000 false 8 0 0 0 false HYKU BIOSCIENCES INC. /s/ Kleem Chaudhary Kleem Chaudhary Chief Executive Officer 2026-01-02